Related references
Note: Only part of the references are listed.MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Hatem Soliman et al.
BMC CANCER (2020)
Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test
Lorenza Mittempergher et al.
TRANSLATIONAL ONCOLOGY (2020)
Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients
Joanna Huszno et al.
ONCOLOGY (2020)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Jieun Lee et al.
CANCER RESEARCH AND TREATMENT (2019)
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S. J. Luen et al.
ANNALS OF ONCOLOGY (2019)
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
Dilan A. Patel et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
Daniel Fernandez-Garcia et al.
BREAST CANCER RESEARCH (2019)
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci et al.
SEMINARS IN CANCER BIOLOGY (2018)
Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer
S. Chae et al.
CURRENT ONCOLOGY (2018)
An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical Biomarkers
Andre Filipe Vieira et al.
FRONTIERS IN MEDICINE (2018)
Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer
A. S. Noman et al.
SCIENTIFIC REPORTS (2017)
Predicting treatment resistance and relapse through circulating DNA
Emma Beddowes et al.
BREAST (2017)
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
Josee-Lyne Ethier et al.
BREAST CANCER RESEARCH (2017)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden et al.
BMC MEDICAL GENOMICS (2015)
Transforming growth factor-, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer
Abeer Bahhnassy et al.
MOLECULAR MEDICINE REPORTS (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Metastasis prevention by targeting the dormant niche
Cyrus M. Ghajar
NATURE REVIEWS CANCER (2015)
Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis
Motoyoshi Endo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
Stephen K. Chia et al.
CLINICAL CANCER RESEARCH (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
IH Benoy et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
